The Aptamer Functionalized Nanocomposite Used for Prostate Cancer Diagnosis and Therapy

Table 1

Specific aptamers against prostate cancer.

Aptamer names	Targets	Types	Ref.
A9, A10, A10-3	PSMA	RNA	Lupold et al., 2002 [17]
A9g, A10L	PSMA	RNA	Rockey et al., 2011 [18]
A10-3.2	PSMA	RNA	Dassie et al., 2009 [19]
A10-3-J1	PSMA	RNA	Leach et al., 2016 [20]
Wy-5a	PC-3	DNA	Wang et al., 2014 [21]
DML-7	PC-3 and DU-145	DNA	Duan et al., 2016 [22]
AMH	DBD (DNA-binding) of AR	DNA	Kouhpayeh et al., 2016 [23]
CSC1, CSC13	DU-145 cells DU-145 stem cells	DNA	Wang et al., 2013 [24]
E3	LNCaP, 22Rv1, PC-3, and DU-145 cells	DNA	Gray et al., 2018 [25]
PSap4#5	PSA	DNA	Savory et al., 2010 [26]
S3.1/S2.2	MUC-1	DNA	Karpik et al., 2017 [27]
AS1411	Nucleolin	DNA	Bates et al., 2009 [28]